Concomitant Transcatheter Edge-to-Edge Treatment of Secondary Tricuspid and Mitral Regurgitation: An Expert Opinion.
暂无分享,去创建一个
M. Metra | M. Taramasso | F. Maisano | E. Agricola | F. Praz | D. Messika‐Zeitoun | A. Margonato | P. Sorajja | R. Hahn | A. Latib | S. Caravita | M. Adamo | C. Godino | R. Estévez-Loureiro | R. V. von Bardeleben | A. Sisinni | N. Fam | L. Conradi
[1] M. Humbert,et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension , 2022, European Respiratory Journal.
[2] M. Metra,et al. Evolution of tricuspid regurgitation after transcatheter edge‐to‐edge mitral valve repair for secondary mitral regurgitation and its impact on mortality , 2022, European journal of heart failure.
[3] H. Thiele,et al. Right Ventricular-Pulmonary Arterial Coupling and Afterload Reserve in Patients Undergoing Transcatheter Tricuspid Valve Repair. , 2022, Journal of the American College of Cardiology.
[4] A. Bagai,et al. Outcomes of Transcatheter Edge-to-Edge Repair, Surgical and Medical Therapy in Combined Mitral and Tricuspid Regurgitation. , 2022, JACC. Cardiovascular interventions.
[5] OUP accepted manuscript , 2022, European Heart Journal.
[6] D. Burkhoff,et al. Invasive Right Ventricular Pressure-Volume Analysis: Basic Principles, Clinical Applications, and Practical Recommendations , 2021, Circulation. Heart failure.
[7] M. Mack,et al. Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation. , 2021, The New England journal of medicine.
[8] B. Prendergast,et al. Transcatheter treatment for tricuspid valve disease. , 2021, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[9] Jeroen J. Bax,et al. Right Ventricular-Pulmonary Arterial Coupling in Patients With HF Secondary MR: Analysis From the COAPT Trial. , 2021, JACC. Cardiovascular interventions.
[10] E. Chung,et al. Right ventricular dysfunction and tricuspid regurgitation in functional mitral regurgitation , 2021, ESC heart failure.
[11] B. Prendergast,et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. , 2021, European heart journal.
[12] S. Zimmer,et al. Leaflet Configuration and Residual Tricuspid Regurgitation after Transcatheter Edge-to-Edge Tricuspid Repair. , 2021, JACC. Cardiovascular interventions.
[13] H. Thiele,et al. Cardiac output states in patients with severe functional tricuspid regurgitation: impact on treatment success and prognosis , 2021, European journal of heart failure.
[14] M. Metra,et al. Percutaneous edge-to-edge mitral valve repair: beyond the left heart. , 2021, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[15] B. Prendergast,et al. Community prevalence, mechanisms and outcome of mitral or tricuspid regurgitation , 2021, Heart.
[16] U. Benedetto,et al. The best approach for functional tricuspid regurgitation: A network meta‐analysis , 2021, Journal of cardiac surgery.
[17] G. Nickenig,et al. Fate of Tricuspid Regurgitation in Patients Undergoing Transcatheter Edge-to-Edge Mitral Valve Repair. , 2021, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[18] M. Guazzi,et al. Non-response to acute vasodilator challenge and prognosis in heart failure with pulmonary hypertension. , 2021, Journal of cardiac failure.
[19] M. Mack,et al. Feasibility Study of the Transcatheter Valve Repair System for Severe Tricuspid Regurgitation. , 2021, Journal of the American College of Cardiology.
[20] C. Butter,et al. Natural course of tricuspid regurgitation and prognostic implications , 2021, Open Heart.
[21] J. Hausleiter,et al. Transcatheter Edge-to-Edge Repair for Treatment of Tricuspid Regurgitation. , 2021, Journal of the American College of Cardiology.
[22] T. Münzel,et al. Concomitant tricuspid regurgitation severity and its secondary reduction determine long-term prognosis after transcatheter mitral valve edge-to-edge repair , 2021, Clinical Research in Cardiology.
[23] W. Gray,et al. Early Feasibility Study of Cardioband Tricuspid System for Functional Tricuspid Regurgitation: 30-Day Outcomes. , 2021, JACC. Cardiovascular interventions.
[24] M. Mack,et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2020, Journal of the American College of Cardiology.
[25] H. Thiele,et al. Cardiopulmonary Hemodynamic Profile Predicts Mortality After Transcatheter Tricuspid Valve Repair in Chronic Heart Failure. , 2020, JACC. Cardiovascular interventions.
[26] L. Badano,et al. Right atrial volume is a major determinant of tricuspid annulus area in functional tricuspid regurgitation: a three-dimensional echocardiographic study. , 2020, European heart journal cardiovascular Imaging.
[27] J. Hausleiter,et al. Two-year Outcomes with the Cardioband Tricuspid System from the Multicentre, Prospective TRI-REPAIR Study. , 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[28] M. Mack,et al. Impact of Tricuspid Regurgitation on Clinical Outcomes: The COAPT Trial. , 2020, Journal of the American College of Cardiology.
[29] M. Guazzi,et al. Pulmonary Hypertension in HFpEF and HFrEF: JACC Review Topic of the Week. , 2020, Journal of the American College of Cardiology.
[30] M. Obokata,et al. Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation. , 2020, Journal of the American College of Cardiology.
[31] M. Metra,et al. Transcatheter therapies for tricuspid valve regurgitation , 2020, Journal of cardiovascular medicine.
[32] Jeroen J. Bax,et al. Impact of tricuspid regurgitation on survival in patients with heart failure: a large electronic health record patient‐level database analysis , 2020, European journal of heart failure.
[33] Shao‐Wei Chen,et al. Late Outcomes of Valve Repair Versus Replacement in Isolated and Concomitant Tricuspid Valve Surgery: A Nationwide Cohort Study , 2020, Journal of the American Heart Association.
[34] H. Michelena,et al. Functional tricuspid regurgitation of degenerative mitral valve disease: a crucial determinant of survival. , 2020, European heart journal.
[35] J. Lessick,et al. Risk Factors for the Development of Functional Tricuspid Regurgitation and Their Population-Attributable Fractions. , 2020, JACC. Cardiovascular imaging.
[36] P. Boekstegers,et al. Combined Tricuspid and Mitral Versus Isolated Mitral Valve Repair for Severe Mitral and Tricuspid Regurgitation: An Analysis From the TriValve and TRAMI Registries. , 2020, JACC. Cardiovascular interventions.
[37] H. Thiele,et al. Clinical characteristics, diagnosis, and risk stratification of pulmonary hypertension in severe tricuspid regurgitation and implications for transcatheter tricuspid valve repair. , 2019, European heart journal.
[38] H. Thiele,et al. Compassionate Use of the PASCAL Transcatheter Valve Repair System for Severe Tricuspid Regurgitation: A Multicenter, Observational, First-in-Human Experience. , 2019, JACC. Cardiovascular interventions.
[39] Jeroen J. Bax,et al. Transcatheter versus medical treatment of symptomatic severe tricuspid regurgitation. , 2019, Journal of the American College of Cardiology.
[40] J. Hausleiter,et al. Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6-month outcomes of the TRILUMINATE single-arm study , 2019, The Lancet.
[41] P. Blanke,et al. Novel Transcatheter Mitral Valve Prosthesis for Patients With Severe Mitral Annular Calcification. , 2019, Journal of the American College of Cardiology.
[42] K. Kuck,et al. 1-Year Outcomes After Edge-to-Edge Valve Repair for Symptomatic Tricuspid Regurgitation: Results From the TriValve Registry. , 2019, JACC. Cardiovascular interventions.
[43] J. Leipsic,et al. Long-Term Outcomes of the FORMA Transcatheter Tricuspid Valve Repair System for the Treatment of Severe Tricuspid Regurgitation: Insights From the First-in-Human Experience. , 2019, JACC. Cardiovascular interventions.
[44] S. Bolling,et al. Tricuspid Regurgitation: Predicting the Need for Intervention, Procedural Success, and Recurrence of Disease. , 2019, JACC. Cardiovascular imaging.
[45] M. Enriquez-Sarano,et al. Burden of Tricuspid Regurgitation in Patients Diagnosed in the Community Setting. , 2019, JACC. Cardiovascular imaging.
[46] S. Rosenkranz,et al. Pulmonary hypertension due to left heart disease , 2019, European Respiratory Journal.
[47] A. Pasquet,et al. Mid-term results of a randomized trial of tricuspid annuloplasty for less-than-severe functional tricuspid regurgitation at the time of mitral valve surgery†. , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[48] Jeroen J. Bax,et al. Development of significant tricuspid regurgitation over time and prognostic implications: new insights into natural history , 2018, European heart journal.
[49] H. Thiele,et al. Combined Mitral and Tricuspid Versus Isolated Mitral Valve Transcatheter Edge-to-Edge Repair in Patients With Symptomatic Valve Regurgitation at High Surgical Risk. , 2018, JACC. Cardiovascular interventions.
[50] H. Thiele,et al. Predictors of Procedural and Clinical Outcomes in Patients With Symptomatic Tricuspid Regurgitation Undergoing Transcatheter Edge-to-Edge Repair. , 2018, JACC. Cardiovascular interventions.
[51] M. Hutyra,et al. Macitentan in pulmonary hypertension due to left ventricular dysfunction , 2018, European Respiratory Journal.
[52] F. Fernández‐Avilés,et al. Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial , 2017, European heart journal.
[53] J. Mehilli,et al. Transcatheter Treatment of Severe Tricuspid Regurgitation Using the Edge-to-Edge Repair Technique in the Presence and Absence of Pacemaker Leads. , 2017, JACC. Cardiovascular interventions.
[54] J. Hausleiter,et al. The International Multicenter TriValve Registry: Which Patients Are Undergoing Transcatheter Tricuspid Repair? , 2017, JACC: Cardiovascular Interventions.
[55] R. Siegel,et al. Postprocedural Changes of Tricuspid Regurgitation After MitraClip Therapy for Mitral Regurgitation. , 2017, The American journal of cardiology.
[56] N. Moat,et al. Tricuspid annuloplasty versus a conservative approach in patients with functional tricuspid regurgitation undergoing left-sided heart valve surgery: A study-level meta-analysis. , 2017, International journal of cardiology.
[57] O. Alfieri,et al. Transcatheter Treatment of Severe Tricuspid Regurgitation With the Edge-to-Edge MitraClip Technique , 2017, Circulation.
[58] J. Schofer,et al. Tricuspid regurgitation is a predictor of mortality after percutaneous mitral valve edge-to-edge repair. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[59] E. Agricola,et al. Effects of functional tricuspid regurgitation on renal function and long-term prognosis in patients with heart failure , 2017, Journal of cardiovascular medicine.
[60] J. Mehilli,et al. Transcatheter treatment of severe tricuspid regurgitation using the edge-to-edge repair technique. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[61] M. Bahls,et al. Cachexia and right ventricular dysfunction in chronic heart failure: what is the chicken and what the egg? , 2016, European heart journal.
[62] F. Ruschitzka,et al. Impact of percutaneous mitral valve repair using the MitraClip system on tricuspid regurgitation. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[63] G. Nickenig,et al. Transcatheter treatment of severe tricuspid regurgitation with the MitraClip system. , 2016, European heart journal.
[64] P. Boekstegers,et al. One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry , 2015, European heart journal.
[65] D. Adams,et al. Impact of Concomitant Tricuspid Annuloplasty on Tricuspid Regurgitation, Right Ventricular Function, and Pulmonary Artery Hypertension After Repair of Mitral Valve Prolapse. , 2015, Journal of the American College of Cardiology.
[66] D. Capodanno,et al. Association of tricuspid regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip System: 30-day and 12-month follow-up from the GRASP Registry. , 2014, European heart journal cardiovascular Imaging.
[67] R. Nishimura,et al. The Hemodynamic Basis of Exercise Intolerance in Tricuspid Regurgitation , 2014, Circulation. Heart failure.
[68] E. Blackstone,et al. Tricuspid regurgitation and right ventricular function after mitral valve surgery with or without concomitant tricuspid valve procedure. , 2013, The Journal of thoracic and cardiovascular surgery.
[69] N. Westerhof,et al. Accurate assessment of load-independent right ventricular systolic function in patients with pulmonary hypertension. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[70] E. Agricola,et al. Impact of functional tricuspid regurgitation on heart failure and death in patients with functional mitral regurgitation and left ventricular dysfunction , 2012, European journal of heart failure.
[71] G. Melina,et al. Prophylactic tricuspid annuloplasty in patients with dilated tricuspid annulus undergoing mitral valve surgery. , 2012, The Journal of thoracic and cardiovascular surgery.
[72] F. Hornero,et al. Factors for development of late significant tricuspid regurgitation after mitral valve replacement: the impact of subvalvular preservation. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[73] B. Lytle,et al. Surgical management of secondary tricuspid valve regurgitation: annulus, commissure, or leaflet procedure? , 2010, The Journal of thoracic and cardiovascular surgery.
[74] M. Ruel,et al. Clinical and echocardiographic impact of functional tricuspid regurgitation repair at the time of mitral valve replacement. , 2009, The Annals of thoracic surgery.
[75] Jong-Min Song,et al. Factors associated with development of late significant tricuspid regurgitation after successful left-sided valve surgery , 2009, Heart.
[76] S. Gallina,et al. Mitral valve surgery for functional mitral regurgitation: should moderate-or-more tricuspid regurgitation be treated? a propensity score analysis. , 2009, The Annals of thoracic surgery.
[77] A. Shiran,et al. Tricuspid regurgitation in mitral valve disease incidence, prognostic implications, mechanism, and management. , 2009, Journal of the American College of Cardiology.
[78] Young‐Bae Park,et al. Development of tricuspid regurgitation late after left-sided valve surgery: a single-center experience with long-term echocardiographic examinations. , 2008, American heart journal.
[79] M. Antunes,et al. Management of tricuspid valve regurgitation , 2005, Heart.
[80] David H Adams,et al. A three-dimensional ring annuloplasty for the treatment of tricuspid regurgitation. , 2006, The Annals of thoracic surgery.
[81] C. Duran,et al. Progression of Tricuspid Regurgitation After Repaired Functional Ischemic Mitral Regurgitation , 2005, Circulation.
[82] G. Dreyfus,et al. Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? , 2005, The Annals of thoracic surgery.
[83] Jeevanantham Rajeswaran,et al. Tricuspid valve repair: durability and risk factors for failure. , 2004, The Journal of thoracic and cardiovascular surgery.
[84] Jayant Nath,et al. Impact of tricuspid regurgitation on long-term survival. , 2004, Journal of the American College of Cardiology.
[85] Jagmeet P. Singh,et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study) , 1999, The American journal of cardiology.
[86] B. Gersh,et al. Surgery for tricuspid regurgitation late after mitral valve replacement. , 1984, Circulation.
[87] A. Carpentier,et al. Surgical management of acquired tricuspid valve disease. , 1974, The Journal of thoracic and cardiovascular surgery.